A Phase 1 study of subcutaneous toripalimab in recurrent or metastatic nasopharyngeal carcinoma.

已完结 10 由妙脆角发布于 2026/10/18 17:12:55

DOI:10.1002/bcp.70796
作者：Hai-Qiang Mai,?Ya-Qian Han,?Kun-Yu Yang,?Guo-Wu Wu,?Chuan-Ben Chen,?Mo Wang,?Xian-Ming Luo,?Shuang-Hui Wei,?Xi Tan,?Hui-Mei Xie,?Jian-Jun Zou,?Rui-Hua Xu
文献类型：期刊论文
补充材料：只需要正文
文献链接：https://doi.org/10.1002/bcp.70796

Wiley

Abstract：Aims: Considering the inconvenience brought by long-term administration of intravenous (IV) immune checkpoint inhibitors for cancer treatment, subcutaneous (SC) formulation needs to be explo

应助信息

求助已完结，文件已删除 如有需求请重新发布求助一键发布

感谢使用Book学术
本站所有文献仅供个人学习和参考，请勿将文件进行传播。共同遵守网站规定和相关知识产权规定。

上一个求助:其它数据库Naturally Fractured Carbonate Reservoir Characterization: A Case Study of a Mature High-Pour Point Oil Field in Hungary 下一个求助:其它数据库A dose-response study following in utero and lactational exposure to di-(2-ethylhexyl) phthalate (DEHP): Effects on reproductive development and function of male offspring rats